+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Ischemic Stroke Drugs Market Size by Type, by Application, by Geographic Scope And Forecast

  • ID: 5301542
  • Report
  • August 2020
  • Region: Global
  • 101 pages
  • Verified Market Research

FEATURED COMPANIES

  • AstraZeneca
  • Bayer Ag
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche Ag
  • Pfizer
  • Sanofi
Acute ischemic stroke (AIS) Market Size And Forecast

The Global Acute ischemic stroke (AIS) Market was valued at USD 8,379.46 Million in 2020 and is projected to reach USD 11,122.12 Million by 2027, growing at a CAGR of 4.13% from 2020 to 2027.

Global Acute ischemic stroke (AIS) Market Overview

The leading cause of ischemic stroke includes hypertension, smoking, diabetes, body fat, and sickle cell disease, etc. Some primary remedies to prevent AIS include proper sleep and blood pressure self-monitoring in hypertensive patients. The global ischemic cerebral stroke drugs market is predicted to expand at a rapid rate during the forecast period due to growing patient awareness for ischemic stroke prevention and the rising geriatric population. In addition, novel drug developments by market players and their approval by the FDA is further accelerating market growth.

Global Acute ischemic stroke (AIS) Market: Segmentation Analysis

The Global Acute ischemic stroke (AIS) Market is segmented on the basis of Type, application, and geography.

Key Players in Acute ischemic stroke (AIS) Market

The Global Acute ischemic stroke (AIS) Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Roche, Boehringer Ingelheim, Bayer, Sanofi, Pfizer, Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Janseen (Johnson & Johnson), AstraZeneca, ZZ Biotech, NoNO Inc., Athersys Inc., and SanBio, F. Hoffmann-La Roche Ag, Boehringer Ingelheim, Bayer Ag, Sanofi S.A., Janssen.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca
  • Bayer Ag
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche Ag
  • Pfizer
  • Sanofi
1 Introduction
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations

2 Research Methodology
2.1 Data Mining
2.2 Secondary Research
2.3 Primary Research
2.4 Subject Matter Expert Advice
2.5 Quality Check
2.6 Final Review
2.7 Data Triangulation
2.8 Bottom-Up Approach
2.9 Top Down Approach
2.10 Research Flow
2.11 Data Sources

3 Executive Summary
3.1 Market Overview
3.2 Global Ischemic Stroke Drugs Market Geographical Analysis (Cagr %)
3.3 Global Ischemic Stroke Drugs Market, by Type (Usd Million)
3.4 Global Ischemic Stroke Drugs Market, by Application (Usd Million)
3.5 Future Market Opportunities
3.6 Global Market Split

4 Market Outlook
4.1 Global Ischemic Stroke Drugs Market Outlook
4.2 Market Drivers
4.2.1 Growing Aging Population
4.2.2 Increasing Prevalence of Acute Ischemic Stroke
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Options
4.4 Market Opportunities
4.4.1 Increasing Adoption of Novel Oral Anticoagulants (Noac)
4.4.2 Manufacturers to Explore Potential Markets in APAC to Meet Unmet Treatment Needs
4.5 Impact of the Covid-19 on the Acute Ischemic Stroke Drugs Industry
4.5.1 Acute Ischemic Stroke Drugs Business Impact Assessment - Covid-19
4.5.2 Supply Chain Challenges
4.6 Market Trends and Acute Ischemic Stroke Drugs Potential Opportunities in the Covid-19 Landscape
4.7 Measures / Proposal Against Covid-19
4.7.1 Government Measures to Combat Covid-19 Impact
4.7.2 Proposal for Acute Ischemic Stroke Drugs Players to Combat Covid-19 Impact
4.8 Pipeline Anlysis
4.9 Porter's Five Forces Analysis

5 Global Ischemic Stroke Drugs Market, by Type
5.1 Overview
5.2 Tablet
5.3 Capsule
5.4 Others

6 Global Ischemic Stroke Drugs Market, by Application
6.1 Overview
6.2 Hospitals
6.3 Diagnostic Centers
6.4 Others

7 Market, by Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 U.K.
7.3.4 Rest of Europe
7.4 China
7.5 Japan

8 Competitive Landscape
8.1 Overview
8.2 Competitive Scenario
8.3 Company Market Ranking Analysis

9 Company Profiles
9.1 F. Hoffmann-La Roche AG
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Segment Breakdown
9.1.4 Product Benchmarking
9.1.5 SWOT Analysis
9.2 Boehringer Ingelheim
9.2.1 Company Overview
9.2.2 Company Insights
9.2.3 Product Benchmarking
9.2.4 SWOT Analysis
9.3 Bayer AG
9.3.1 Company Overview
9.3.2 Company Insights
9.3.3 Segment Breakdown
9.3.4 Product Benchmarking
9.3.5 SWOT Analysis
9.4 Sanofi S.A.
9.4.1 Company Overview
9.4.2 Company Insights
9.4.3 Segment Breakdown
9.4.4 Product Benchmarking
9.4.5 SWOT Analysis
9.5 Pfizer Inc.
9.5.1 Company Overview
9.5.2 Company Insights
9.5.3 Segment Breakdown
9.5.4 Product Benchmarking
9.5.5 SWOT Analysis
9.7 Biogen Inc
9.7.1 Company Overview
9.7.2 Company Insights
9.7.3 Segment Breakdown
9.7.4 Product Benchmarking
9.8 Daiichi Sankyo Company, Limited
9.8.1 Company Overview
9.8.2 Company Insights
9.8.3 Segment Breakdown
9.8.4 Product Benchmarking
9.9 Bristol-Myers Squibb Company
9.9.1 Company Overview
9.9.2 Company Insights
9.9.3 Segment Breakdown
9.9.4 Product Benchmarking
9.9.5 Key Developments
9.10 Astrazeneca
9.10.1 Company Overview
9.10.2 Company Insights
9.10.3 Segment Breakdown
9.10.4 Product Benchmarking
9.10.5 Key Developments
9.11 Zz Biotech, LLC
9.11.1 Company Overview
9.11.2 Company Insights
9.11.3 Product Benchmarking
9.12 Nono Inc.
9.12.1 Company Overview
9.12.2 Company Insights
9.12.3 Product Benchmarking
9.13 Athersys, Inc.
9.13.1 Company Overview
9.13.2 Company Insights
9.13.3 Product Benchmarking
9.14 Sanbio Co, Ltd.
9.14.1 Company Overview
9.14.2 Company Insights
9.14.3 Product Benchmarking
9.15 Janssen
9.15.1 Company Overview
9.15.2 Company Insights
9.15.3 Segment Breakdown
9.15.4 Product Benchmarking
Note: Product cover images may vary from those shown
  • Roche
  • Boehringer Ingelheim
  • Bayer
  • Sanofi
  • Pfizer
  • Biogen
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Janseen (Johnson & Johnson)
  • AstraZeneca
  • ZZ Biotech
  • NoNO Inc.
  • Athersys Inc.
  • SanBio
  • F. Hoffmann-La Roche Ag
  • Boehringer Ingelheim
  • Bayer Ag
  • Sanofi S.A.
  • Janssen
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll